The characteristics of genome-wide DNA methylation in naïve CD4+ T cells of patients with psoriasis or atopic dermatitis
Highlights
► Some pericentomeric regions were markedly hypomethylated in psoriasis. ► The 121 genes’s promoter on chromosome X had elevated methylation in psoriasis. ► The X chromosome immune-related genes had higher hypermethylation than other genes. ► Methylation changes in naïve CD4+ T cells may affect the pathogenesis of psoriasis.
Introduction
Psoriasis and atopic dermatitis (AD) are common inflammatory skin diseases associated with CD4+ T cell polarization [1], [2]. CD4+ T cells arise from naïve CD4+ T cells. However, naïve CD4+ T cells in psoriasis mainly differentiate into T helper type 1 (Th1) cells in response to Th1 cytokines such as interferon (IFN)-γ [1]. In contrast, AD is predominantly a Th2-polarized disease involving Th2 cytokines such as interleukin (IL)-4 and IL-5 [2]. Immune responses related to T cell polarization are regulated by epigenetic changes [3], [4]. These epigenetic changes may be involved in various skin diseases, including systemic lupus erythematosus and vitiligo [5], [6], [7]. However, the epigenetic changes of naïve CD4+ T cells during psoriasis and AD are not yet fully understood.
Epigenetic regulation of gene expression is a dynamic process in which DNA methylation is a primary mechanism [8]. In mammals, methylation occurs predominantly on CpG dinucleotides that are sparsely distributed within the genome. CpG methylation regulates and stabilizes chromatin structure and controls the recruitment of transcriptional machinery [9]. In general, regulation of CpG methylation is established and maintained by DNA methyltransferases [9]. Karen et al. demonstrated that the expression of Th2 cytokines, such as IL-4, was regulated by DNA methyltransferase-1 in CD4+ T cells [10]. Based on findings from a previous study, proper maintenance of DNA methylation may be critical for the polarization of CD4+ T cells and the development of diseases such as psoriasis and AD. Because psoriasis and AD are associated with improper immune responses, such as imbalanced CD4+ T cell populations, fine-tuning T cell heritage may be important for managing these two diseases [1], [2]. With this hypothesis, we investigated whether DNA methylation in naïve CD4+ T cells is associated with the development of psoriasis and AD.
Here, we describe the genome-wide profile of methylation changes in naïve CD4+ T cells from patients with psoriasis or AD as compared with those of healthy controls. First, we surveyed the global changes along the chromosomes irrespective of gene loci, and found many regions that underwent hypomethylation in patients with psoriasis, not AD. The gene-centric analysis comparing the methylation changes of both promoter and gene-body regions indicated that gene promoter regions on the X chromosome were dramatically hypermethylated in patients with psoriasis. No such patterns were observed with AD patient T cells. Our findings indicate that methylation changes in naïve CD4+ T cells may have important roles during CD4+ T cell polarization, especially in the pathogenesis of psoriasis. Further study of CD4+ T cell polarization based on changes in DNA methylation is necessary to understand the development of psoriasis and AD.
Section snippets
Subjects
Peripheral blood samples were obtained from 12 patients with plaque type psoriasis, 15 patients with atopic dermatitis and 10 healthy controls in each experiment. Patients with psoriasis or AD were restricted from taking systemic glucocorticoids, topical corticosteroids and immune-suppressants during at least 4 weeks before blood collection. Detailed information of the subjects included in the study is listed in Supplementary Table 1. For controls, healthy subjects who have no history of
Global changes in DNA methylation in naïve CD4+ T cells from patients with psoriasis or AD
To determine whether naïve CD4+ T cells from patients with psoriasis or AD have different DNA methylation patterns than those from healthy controls, we performed comprehensive CpG methylation profiling of whole genomes. Genomic DNA samples isolated from naïve CD4+ T cells were separately pooled from patients with psoriasis or AD, and from healthy controls. To measure the enrichment of local methylation signals, methylation enrichment scores (MESs) were calculated (see Section 2 for definition).
Discussion
We have performed the genome-wide analysis of DNA methylation in naïve CD4+ T cells from patients with psoriasis and AD. Compare to previous study [24], [25], our results provide detailed methylation analysis of psoriasis and AD. We found that the pattern of DNA methylation has increased dramatically in the promoter region of genes on the X chromosome in patients with psoriasis. The X chromosome encodes many immune-related genes [22]. The immune-related genes on the X chromosome showed higher
Acknowledgments
This work was supported by grants from the National Research Foundation of Korea (NRF) funded by the Korea government (MEST) (No. 20110027837 & 20100021811) and the Next-Generation BioGreen 21 Program (No. PJ007991), Rural Development Administration, Korea.
References (26)
- et al.
A critical role for Dnmt1 and DNA methylation in T cell development, function, and survival
Immunity
(2001) - et al.
DNA methylation
Blood
(1999) - et al.
Centromeric DNA hypomethylation as an epigenetic signature discriminates between germ and somatic cell lineages
Dev. Biol.
(2007) - et al.
Abnormal DNA methylation in skin lesions and PBMCs of patients with psoriasis vulgaris
J Dermatol Sci.
(2010) - et al.
Psoriasis
N. Engl. J. Med.
(2009) Atopic dermatitis
N. Engl. J. Med.
(2008)- et al.
An epigenetic view of helper T cell differentiation
Nat. Immunol.
(2003) - et al.
Transcript levels of DNA methyltransferases DNMT1, DNMT3A and DNMT3B in CD4+ T cells from patients with systemic lupus erythematosus
Immunology
(2008) - et al.
Abnormal DNA methylation in CD4+ T cells from patients with systemic lupus erythematosus, systemic sclerosis, and dermatomyositis
Scand. J. Rheumatol.
(2009) - et al.
Abnormal DNA methylation in peripheral blood mononuclear cells from patients with vitiligo
Br. J. Dermatol.
(2010)
Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals
Nat. Genet.
DNA methylation is a nonredundant repressor of the Th2 effector program
J. Immunol.
Developmental and hormone-induced epigenetic changes to estrogen and progesterone receptor genes in brain are dynamic across the life span
Endocrinology
Cited by (49)
DZ2002 alleviates psoriasis-like skin lesions via differentially regulating methylation of GATA3 and LCN2 promoters
2021, International ImmunopharmacologyEpigenetics and precision medicine in skin diseases
2021, Epigenetics in Precision MedicineEpigenetic factors involved in the pathophysiology of inflammatory skin diseases
2020, Journal of Allergy and Clinical ImmunologyEpigenetic deregulation of immune cells in autoimmune and autoinflammatory diseases
2020, Epigenetics of the Immune SystemEpigenetic Changes in Chronic Inflammatory Diseases
2017, Advances in Protein Chemistry and Structural BiologyCitation Excerpt :Most DMRs were associated with other epigenomic signals like histone modifications or transcription factor-binding sites. When focusing on gene-related sequence features 124 genes were identified to be hypermethylated within the promoter regions, most of them (n = 121) being immune-related genes located on the X chromosome (Han et al., 2012). Using MeDIP-seq technology, these results were confirmed on sorted CD4+ T cells (Park et al., 2014).
Epigenetics of psoriatic disease: A systematic review and critical appraisal
2017, Journal of AutoimmunityCitation Excerpt :Candidate genes were thus chosen based on the existing knowledge of psoriasis pathogenesis at the time, demonstrating aberrant CpG methylation at SHP-1, p15, p16, and p21 [41–43]. The question of whether aberrant methylation or histone marks occur near the more recently identified genetic susceptibility loci, namely, HLA-C*06, has been directly addressed in only two studies, with both positive [49] and negative results [61], and indirectly addressed through genome-wide methylation analyses [50,51,55,57,58]. These latter studies have, for the most part, uncovered loci that do not overlap with known psoriatic disease genetic susceptibility loci, but do play roles in important biological pathways in psoriatic disease, such as immune regulation, inflammation, and epidermal proliferation.
- 1
These authors contributed equally to this work.